Literature DB >> 21593217

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Antonis C Antoniou1, Christiana Kartsonaki, Olga M Sinilnikova, Penny Soucy, Lesley McGuffog, Sue Healey, Andrew Lee, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Elisa Cattaneo, Monica Barile, Valeria Pensotti, Barbara Pasini, Riccardo Dolcetti, Giuseppe Giannini, Anna Laura Putignano, Liliana Varesco, Paolo Radice, Phuong L Mai, Mark H Greene, Irene L Andrulis, Gord Glendon, Hilmi Ozcelik, Mads Thomassen, Anne-Marie Gerdes, Torben A Kruse, Uffe Birk Jensen, Dorthe G Crüger, Maria A Caligo, Yael Laitman, Roni Milgrom, Bella Kaufman, Shani Paluch-Shimon, Eitan Friedman, Niklas Loman, Katja Harbst, Annika Lindblom, Brita Arver, Hans Ehrencrona, Beatrice Melin, Katherine L Nathanson, Susan M Domchek, Timothy Rebbeck, Ania Jakubowska, Jan Lubinski, Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski, Cezary Cybulski, Bohdan Gorski, Ana Osorio, Teresa Ramón y Cajal, Florentia Fostira, Raquel Andrés, Javier Benitez, Ute Hamann, Frans B Hogervorst, Matti A Rookus, Maartje J Hooning, Marcel R Nelen, Rob B van der Luijt, Theo A M van Os, Christi J van Asperen, Peter Devilee, Hanne E J Meijers-Heijboer, Encarna B Gómez Garcia, Susan Peock, Margaret Cook, Debra Frost, Radka Platte, Jean Leyland, D Gareth Evans, Fiona Lalloo, Ros Eeles, Louise Izatt, Julian Adlard, Rosemarie Davidson, Diana Eccles, Kai-ren Ong, Jackie Cook, Fiona Douglas, Joan Paterson, M John Kennedy, Zosia Miedzybrodzka, Andrew Godwin, Dominique Stoppa-Lyonnet, Bruno Buecher, Muriel Belotti, Carole Tirapo, Sylvie Mazoyer, Laure Barjhoux, Christine Lasset, Dominique Leroux, Laurence Faivre, Myriam Bronner, Fabienne Prieur, Catherine Nogues, Etienne Rouleau, Pascal Pujol, Isabelle Coupier, Marc Frénay, John L Hopper, Mary B Daly, Mary B Terry, Esther M John, Saundra S Buys, Yosuf Yassin, Alexander Miron, David Goldgar, Christian F Singer, Muy-Kheng Tea, Georg Pfeiler, Anne Catharina Dressler, Thomas v O Hansen, Lars Jønson, Bent Ejlertsen, Rosa Bjork Barkardottir, Tomas Kirchhoff, Kenneth Offit, Marion Piedmonte, Gustavo Rodriguez, Laurie Small, John Boggess, Stephanie Blank, Jack Basil, Masoud Azodi, Amanda Ewart Toland, Marco Montagna, Silvia Tognazzo, Simona Agata, Evgeny Imyanitov, Ramunas Janavicius, Conxi Lazaro, Ignacio Blanco, Paul D P Pharoah, Lara Sucheston, Beth Y Karlan, Christine S Walsh, Edith Olah, Aniko Bozsik, Soo-Hwang Teo, Joyce L Seldon, Mary S Beattie, Elizabeth J van Rensburg, Michelle D Sluiter, Orland Diez, Rita K Schmutzler, Barbara Wappenschmidt, Christoph Engel, Alfons Meindl, Ina Ruehl, Raymonda Varon-Mateeva, Karin Kast, Helmut Deissler, Dieter Niederacher, Norbert Arnold, Dorothea Gadzicki, Ines Schönbuchner, Trinidad Caldes, Miguel de la Hoya, Heli Nevanlinna, Kristiina Aittomäki, Martine Dumont, Jocelyne Chiquette, Marc Tischkowitz, Xiaoqing Chen, Jonathan Beesley, Amanda B Spurdle, Susan L Neuhausen, Yuan Chun Ding, Zachary Fredericksen, Xianshu Wang, Vernon S Pankratz, Fergus Couch, Jacques Simard, Douglas F Easton, Georgia Chenevix-Trench.   

Abstract

Two single nucleotide polymorphisms (SNPs) at 6q25.1, near the ESR1 gene, have been implicated in the susceptibility to breast cancer for Asian (rs2046210) and European women (rs9397435). A genome-wide association study in Europeans identified two further breast cancer susceptibility variants: rs11249433 at 1p11.2 and rs999737 in RAD51L1 at 14q24.1. Although previously identified breast cancer susceptibility variants have been shown to be associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, the involvement of these SNPs to breast cancer susceptibility in mutation carriers is currently unknown. To address this, we genotyped these SNPs in BRCA1 and BRCA2 mutation carriers from 42 studies from the Consortium of Investigators of Modifiers of BRCA1/2. In the analysis of 14 123 BRCA1 and 8053 BRCA2 mutation carriers of European ancestry, the 6q25.1 SNPs (r(2) = 0.14) were independently associated with the risk of breast cancer for BRCA1 mutation carriers [hazard ratio (HR) = 1.17, 95% confidence interval (CI): 1.11-1.23, P-trend = 4.5 × 10(-9) for rs2046210; HR = 1.28, 95% CI: 1.18-1.40, P-trend = 1.3 × 10(-8) for rs9397435], but only rs9397435 was associated with the risk for BRCA2 carriers (HR = 1.14, 95% CI: 1.01-1.28, P-trend = 0.031). SNP rs11249433 (1p11.2) was associated with the risk of breast cancer for BRCA2 mutation carriers (HR = 1.09, 95% CI: 1.02-1.17, P-trend = 0.015), but was not associated with breast cancer risk for BRCA1 mutation carriers (HR = 0.97, 95% CI: 0.92-1.02, P-trend = 0.20). SNP rs999737 (RAD51L1) was not associated with breast cancer risk for either BRCA1 or BRCA2 mutation carriers (P-trend = 0.27 and 0.30, respectively). The identification of SNPs at 6q25.1 associated with breast cancer risk for BRCA1 mutation carriers will lead to a better understanding of the biology of tumour development in these women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593217      PMCID: PMC3652640          DOI: 10.1093/hmg/ddr226

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.

Authors:  Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

Review 2.  Preventive therapy for breast cancer: a consensus statement.

Authors:  Jack Cuzick; Andrea DeCensi; Banu Arun; Powel H Brown; Monica Castiglione; Barbara Dunn; John F Forbes; Agnes Glaus; Anthony Howell; Gunter von Minckwitz; Victor Vogel; Heinz Zwierzina
Journal:  Lancet Oncol       Date:  2011-05       Impact factor: 41.316

3.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

4.  The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

Authors:  Sunil R Lakhani; Marc J Van De Vijver; Jocelyne Jacquemier; Thomas J Anderson; Peter P Osin; Lesley McGuffog; Douglas F Easton
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

5.  The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.

Authors:  Irene Catucci; Paolo Verderio; Sara Pizzamiglio; Siranoush Manoukian; Bernard Peissel; Daniela Zaffaroni; Gaia Roversi; Carla B Ripamonti; Barbara Pasini; Monica Barile; Alessandra Viel; Giuseppe Giannini; Laura Papi; Liliana Varesco; Aline Martayan; Mirko Riboni; Sara Volorio; Paolo Radice; Paolo Peterlongo
Journal:  Breast Cancer Res Treat       Date:  2010-07-22       Impact factor: 4.872

6.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

7.  Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.

Authors:  Qiuyin Cai; Wanqing Wen; Shimian Qu; Guoliang Li; Kathleen M Egan; Kexin Chen; Sandra L Deming; Hongbing Shen; Chen-Yang Shen; Marilie D Gammon; William J Blot; Keitaro Matsuo; Christopher A Haiman; Ui Soon Khoo; Motoki Iwasaki; Regina M Santella; Lina Zhang; Alecia Malin Fair; Zhibin Hu; Pei-Ei Wu; Lisa B Signorello; Linda Titus-Ernstoff; Kazuo Tajima; Brian E Henderson; Kelvin Y K Chan; Yoshio Kasuga; Polly A Newcomb; Hong Zheng; Yong Cui; Furu Wang; Ya-Lan Shieh; Hiroji Iwata; Loic Le Marchand; Sum Yin Chan; Martha J Shrubsole; Amy Trentham-Dietz; Shoichiro Tsugane; Montserrat Garcia-Closas; Jirong Long; Chun Li; Jiajun Shi; Bo Huang; Yong-Bing Xiang; Yu-Tang Gao; Wei Lu; Xiao-Ou Shu; Wei Zheng
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

Review 8.  Endocrine-responsive breast cancer and strategies for combating resistance.

Authors:  Simak Ali; R Charles Coombes
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

9.  Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

Authors:  Susan J Ramus; Christiana Kartsonaki; Simon A Gayther; Paul D P Pharoah; Olga M Sinilnikova; Jonathan Beesley; Xiaoqing Chen; Lesley McGuffog; Sue Healey; Fergus J Couch; Xianshu Wang; Zachary Fredericksen; Paolo Peterlongo; Siranoush Manoukian; Bernard Peissel; Daniela Zaffaroni; Gaia Roversi; Monica Barile; Alessandra Viel; Anna Allavena; Laura Ottini; Laura Papi; Viviana Gismondi; Fabio Capra; Paolo Radice; Mark H Greene; Phuong L Mai; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Mads Thomassen; Anne-Marie Gerdes; Torben A Kruse; Dorthe Cruger; Uffe Birk Jensen; Maria Adelaide Caligo; Håkan Olsson; Ulf Kristoffersson; Annika Lindblom; Brita Arver; Per Karlsson; Marie Stenmark Askmalm; Ake Borg; Susan L Neuhausen; Yuan Chun Ding; Katherine L Nathanson; Susan M Domchek; Anna Jakubowska; Jan Lubiński; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Bohdan Górski; Cezary Cybulski; Tadeusz Dębniak; Ana Osorio; Mercedes Durán; Maria-Isabel Tejada; Javier Benítez; Ute Hamann; Matti A Rookus; Senno Verhoef; Madeleine A Tilanus-Linthorst; Maaike P Vreeswijk; Danielle Bodmer; Margreet G E M Ausems; Theo A van Os; Christi J Asperen; Marinus J Blok; Hanne E J Meijers-Heijboer; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Alison M Dunning; D Gareth Evans; Ros Eeles; Gabriella Pichert; Trevor Cole; Shirley Hodgson; Carole Brewer; Patrick J Morrison; Mary Porteous; M John Kennedy; Mark T Rogers; Lucy E Side; Alan Donaldson; Helen Gregory; Andrew Godwin; Dominique Stoppa-Lyonnet; Virginie Moncoutier; Laurent Castera; Sylvie Mazoyer; Laure Barjhoux; Valérie Bonadona; Dominique Leroux; Laurence Faivre; Rosette Lidereau; Catherine Nogues; Yves-Jean Bignon; Fabienne Prieur; Marie-Agnès Collonge-Rame; Laurence Venat-Bouvet; Sandra Fert-Ferrer; Alex Miron; Saundra S Buys; John L Hopper; Mary B Daly; Esther M John; Mary Beth Terry; David Goldgar; Thomas v O Hansen; Lars Jønson; Bent Ejlertsen; Bjarni A Agnarsson; Kenneth Offit; Tomas Kirchhoff; Joseph Vijai; Ana V C Dutra-Clarke; Jennifer A Przybylo; Marco Montagna; Cinzia Casella; Evgeny N Imyanitov; Ramunas Janavicius; Ignacio Blanco; Conxi Lázaro; Kirsten B Moysich; Beth Y Karlan; Jenny Gross; Mary S Beattie; Rita Schmutzler; Barbara Wappenschmidt; Alfons Meindl; Ina Ruehl; Britta Fiebig; Christian Sutter; Norbert Arnold; Helmut Deissler; Raymonda Varon-Mateeva; Karin Kast; Dieter Niederacher; Dorothea Gadzicki; Trinidad Caldes; Miguel de la Hoya; Heli Nevanlinna; Kristiina Aittomäki; Jacques Simard; Penny Soucy; Amanda B Spurdle; Helene Holland; Georgia Chenevix-Trench; Douglas F Easton; Antonis C Antoniou
Journal:  J Natl Cancer Inst       Date:  2010-12-17       Impact factor: 13.506

10.  ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.

Authors:  Anita K Dunbier; Helen Anderson; Zara Ghazoui; Elena Lopez-Knowles; Sunil Pancholi; Ricardo Ribas; Suzanne Drury; Kally Sidhu; Alexandra Leary; Lesley-Ann Martin; Mitch Dowsett
Journal:  PLoS Genet       Date:  2011-04-28       Impact factor: 5.917

View more
  46 in total

1.  Fine mapping of 14q24.1 breast cancer susceptibility locus.

Authors:  Phoebe Lee; Yi-Ping Fu; Jonine D Figueroa; Ludmila Prokunina-Olsson; Jesus Gonzalez-Bosquet; Peter Kraft; Zhaoming Wang; Kevin B Jacobs; Meredith Yeager; Marie-Josèphe Horner; Susan E Hankinson; Amy Hutchinson; Nilanjan Chatterjee; Montserrat Garcia-Closas; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Michael J Thun; Ryan Diver; Ross Prentice; Rebecca Jackson; Charles Kooperberg; Rowan Chlebowski; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Margaret Tucker; Joseph F Fraumeni; Robert N Hoover; Gilles Thomas; David J Hunter; Stephen J Chanock
Journal:  Hum Genet       Date:  2011-09-30       Impact factor: 4.132

2.  Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

Authors:  Alison M Dunning; Kyriaki Michailidou; Karoline B Kuchenbaecker; Deborah Thompson; Juliet D French; Jonathan Beesley; Catherine S Healey; Siddhartha Kar; Karen A Pooley; Elena Lopez-Knowles; Ed Dicks; Daniel Barrowdale; Nicholas A Sinnott-Armstrong; Richard C Sallari; Kristine M Hillman; Susanne Kaufmann; Haran Sivakumaran; Mahdi Moradi Marjaneh; Jason S Lee; Margaret Hills; Monika Jarosz; Suzie Drury; Sander Canisius; Manjeet K Bolla; Joe Dennis; Qin Wang; John L Hopper; Melissa C Southey; Annegien Broeks; Marjanka K Schmidt; Artitaya Lophatananon; Kenneth Muir; Matthias W Beckmann; Peter A Fasching; Isabel Dos-Santos-Silva; Julian Peto; Elinor J Sawyer; Ian Tomlinson; Barbara Burwinkel; Frederik Marme; Pascal Guénel; Thérèse Truong; Stig E Bojesen; Henrik Flyger; Anna González-Neira; Jose I A Perez; Hoda Anton-Culver; Lee Eunjung; Volker Arndt; Hermann Brenner; Alfons Meindl; Rita K Schmutzler; Hiltrud Brauch; Ute Hamann; Kristiina Aittomäki; Carl Blomqvist; Hidemi Ito; Keitaro Matsuo; Natasha Bogdanova; Thilo Dörk; Annika Lindblom; Sara Margolin; Veli-Matti Kosma; Arto Mannermaa; Chiu-Chen Tseng; Anna H Wu; Diether Lambrechts; Hans Wildiers; Jenny Chang-Claude; Anja Rudolph; Paolo Peterlongo; Paolo Radice; Janet E Olson; Graham G Giles; Roger L Milne; Christopher A Haiman; Brian E Henderson; Mark S Goldberg; Soo H Teo; Cheng Har Yip; Silje Nord; Anne-Lise Borresen-Dale; Vessela Kristensen; Jirong Long; Wei Zheng; Katri Pylkäs; Robert Winqvist; Irene L Andrulis; Julia A Knight; Peter Devilee; Caroline Seynaeve; Jonine Figueroa; Mark E Sherman; Kamila Czene; Hatef Darabi; Antoinette Hollestelle; Ans M W van den Ouweland; Keith Humphreys; Yu-Tang Gao; Xiao-Ou Shu; Angela Cox; Simon S Cross; William Blot; Qiuyin Cai; Maya Ghoussaini; Barbara J Perkins; Mitul Shah; Ji-Yeob Choi; Daehee Kang; Soo Chin Lee; Mikael Hartman; Maria Kabisch; Diana Torres; Anna Jakubowska; Jan Lubinski; Paul Brennan; Suleeporn Sangrajrang; Christine B Ambrosone; Amanda E Toland; Chen-Yang Shen; Pei-Ei Wu; Nick Orr; Anthony Swerdlow; Lesley McGuffog; Sue Healey; Andrew Lee; Miroslav Kapuscinski; Esther M John; Mary Beth Terry; Mary B Daly; David E Goldgar; Saundra S Buys; Ramunas Janavicius; Laima Tihomirova; Nadine Tung; Cecilia M Dorfling; Elizabeth J van Rensburg; Susan L Neuhausen; Bent Ejlertsen; Thomas V O Hansen; Ana Osorio; Javier Benitez; Rachel Rando; Jeffrey N Weitzel; Bernardo Bonanni; Bernard Peissel; Siranoush Manoukian; Laura Papi; Laura Ottini; Irene Konstantopoulou; Paraskevi Apostolou; Judy Garber; Muhammad Usman Rashid; Debra Frost; Louise Izatt; Steve Ellis; Andrew K Godwin; Norbert Arnold; Dieter Niederacher; Kerstin Rhiem; Nadja Bogdanova-Markov; Charlotte Sagne; Dominique Stoppa-Lyonnet; Francesca Damiola; Olga M Sinilnikova; Sylvie Mazoyer; Claudine Isaacs; Kathleen B M Claes; Kim De Leeneer; Miguel de la Hoya; Trinidad Caldes; Heli Nevanlinna; Sofia Khan; Arjen R Mensenkamp; Maartje J Hooning; Matti A Rookus; Ava Kwong; Edith Olah; Orland Diez; Joan Brunet; Miquel Angel Pujana; Jacek Gronwald; Tomasz Huzarski; Rosa B Barkardottir; Rachel Laframboise; Penny Soucy; Marco Montagna; Simona Agata; Manuel R Teixeira; Sue Kyung Park; Noralane Lindor; Fergus J Couch; Marc Tischkowitz; Lenka Foretova; Joseph Vijai; Kenneth Offit; Christian F Singer; Christine Rappaport; Catherine M Phelan; Mark H Greene; Phuong L Mai; Gad Rennert; Evgeny N Imyanitov; Peter J Hulick; Kelly-Anne Phillips; Marion Piedmonte; Anna Marie Mulligan; Gord Glendon; Anders Bojesen; Mads Thomassen; Maria A Caligo; Sook-Yee Yoon; Eitan Friedman; Yael Laitman; Ake Borg; Anna von Wachenfeldt; Hans Ehrencrona; Johanna Rantala; Olufunmilayo I Olopade; Patricia A Ganz; Robert L Nussbaum; Simon A Gayther; Katherine L Nathanson; Susan M Domchek; Banu K Arun; Gillian Mitchell; Beth Y Karlan; Jenny Lester; Gertraud Maskarinec; Christy Woolcott; Christopher Scott; Jennifer Stone; Carmel Apicella; Rulla Tamimi; Robert Luben; Kay-Tee Khaw; Åslaug Helland; Vilde Haakensen; Mitch Dowsett; Paul D P Pharoah; Jacques Simard; Per Hall; Montserrat García-Closas; Celine Vachon; Georgia Chenevix-Trench; Antonis C Antoniou; Douglas F Easton; Stacey L Edwards
Journal:  Nat Genet       Date:  2016-02-29       Impact factor: 38.330

Review 3.  Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

Authors:  Tara M Friebel; Susan M Domchek; Timothy R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2014-06       Impact factor: 13.506

4.  Breast Cancer Risk - Genes, Environment and Clinics.

Authors:  P A Fasching; A B Ekici; B R Adamietz; D L Wachter; A Hein; C M Bayer; L Häberle; C R Loehberg; S M Jud; K Heusinger; M Rübner; C Rauh; M R Bani; M P Lux; R Schulz-Wendtland; A Hartmann; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

5.  Analyzing 395,793 samples shows significant association between rs999737 polymorphism and breast cancer.

Authors:  Haiying Dong; Zhiying Gao; Chengchong Li; Junping Wang; Ming Jin; Hua Rong; Yingcai Niu; Jicheng Liu
Journal:  Tumour Biol       Date:  2014-04-12

Review 6.  Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.

Authors:  Lori M Minasian; Catherine M Tangen; D Lawrence Wickerham
Journal:  Semin Oncol       Date:  2015-07-10       Impact factor: 4.929

Review 7.  Genomic Biomarkers for Breast Cancer Risk.

Authors:  Michael F Walsh; Katherine L Nathanson; Fergus J Couch; Kenneth Offit
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

8.  Two decades after BRCA: setting paradigms in personalized cancer care and prevention.

Authors:  Fergus J Couch; Katherine L Nathanson; Kenneth Offit
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

9.  Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Authors:  P A Fasching; A B Ekici; D L Wachter; A Hein; C M Bayer; L Häberle; C R Loehberg; M Schneider; S M Jud; K Heusinger; M Rübner; C Rauh; M R Bani; M P Lux; R Schulz-Wendtland; A Hartmann; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

Review 10.  Genetic susceptibility to triple-negative breast cancer.

Authors:  Kristen N Stevens; Celine M Vachon; Fergus J Couch
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.